English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Case  Approximately 3%‐25% of cases of endometrial carcinoma ( EC ) or atypical endometrial hyperplasia ( AH ) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate ( MPA ) is administered to women who wish to preserve their fertility. Here is reported the pregnancy outcomes of patients with  EC  or  AH  who received  MPA  therapy at Tokushima University Hospital, Tokushima, Japan. The frequency of pregnancy and live births among the patients with  EC  or  AH  who received conservative treatment, followed by fertility treatment, were analyzed retrospectively.    Outcome  Twelve patients underwent fertility examinations and received fertility treatment immediately after the completion of conservative treatment for  EC  or  AH . One patient had the complication of severe diabetes and total embryo cryopreservation was performed before her diabetes was treated. Among the other 11 patients, 8 (72.7%) became pregnant at least once and 6 (54.5%) experienced at least 1 live birth. Three patients (25.0%) suffered disease recurrence during or after the infertility treatment and all of the recurrences occurred in the  EC  cohort.    Conclusion  When patients with  EC  or  AH  wish to preserve their fertility, it is recommended that prompt and effective fertility treatment, including assisted reproductive technology, should be initiated just after conservative treatment because  EC  and  AH  exhibit relatively high recurrence rates among conservatively treated patients.

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia